Renaissance Technologies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-48,124
| Closed | -$548K | – | 3986 |
|
|
2024
Q3 | $548K | Buy |
+48,124
| New | +$483K | ﹤0.01% | 2749 |
|
|
2023
Q4 | – | Sell |
-115,884
| Closed | -$1.09M | – | 4220 |
|
|
2023
Q3 | $1.09M | Buy |
+115,884
| New | +$1.39M | ﹤0.01% | 2234 |
|
|
2021
Q4 | – | Sell |
-30,784
| Closed | -$664K | – | 4290 |
|
|
2021
Q3 | $664K | Sell |
30,784
-84,412
| -73% | -$2.04M | ﹤0.01% | 2763 |
|
|
2021
Q2 | $2.96M | Buy |
115,196
+23,312
| +25% | +$498K | ﹤0.01% | 1985 |
|
|
2021
Q1 | $1.68M | Buy |
91,884
+65,025
| +242% | +$1.08M | ﹤0.01% | 2329 |
|
|
2020
Q4 | $310K | Buy |
26,859
+3,917
| +17% | +$35.8K | ﹤0.01% | 3021 |
|
|
2020
Q3 | $175K | Sell |
22,942
-149,364
| -87% | -$1.13M | ﹤0.01% | 3135 |
|
|
2020
Q2 | $1.13M | Sell |
172,306
-92,500
| -35% | -$516K | ﹤0.01% | 2483 |
|
|
2020
Q1 | $1.35M | Sell |
264,806
-102,784
| -28% | -$622K | ﹤0.01% | 2263 |
|
|
2019
Q4 | $2.82M | Buy |
367,590
+186,584
| +103% | +$1.09M | ﹤0.01% | 2160 |
|
|
2019
Q3 | $959K | Buy |
181,006
+4,000
| +2% | +$24.8K | ﹤0.01% | 2621 |
|
|
2019
Q2 | $991K | Sell |
177,006
-49,524
| -22% | -$204K | ﹤0.01% | 2682 |
|
|
2019
Q1 | $963K | Sell |
226,530
-196,827
| -46% | -$803K | ﹤0.01% | 2687 |
|
|
2018
Q4 | $1.74M | Buy |
423,357
+123,851
| +41% | +$646K | ﹤0.01% | 2313 |
|
|
2018
Q3 | $2.06M | Buy |
299,506
+4,100
| +1% | +$24.3K | ﹤0.01% | 2264 |
|
|
2018
Q2 | $1.16M | Sell |
295,406
-221,194
| -43% | -$767K | ﹤0.01% | 2540 |
|
|
2018
Q1 | $1.51M | Sell |
516,600
-32,506
| -6% | -$100K | ﹤0.01% | 2474 |
|
|
2017
Q4 | $2.13M | Buy |
549,106
+1,916
| +0.4% | +$8.21K | ﹤0.01% | 2305 |
|
|
2017
Q3 | $1.72M | Buy |
547,190
+66,040
| +14% | +$248K | ﹤0.01% | 2357 |
|
|
2017
Q2 | $2.05M | Buy |
481,150
+41,485
| +9% | +$170K | ﹤0.01% | 2254 |
|
|
2017
Q1 | $2.01M | Buy |
439,665
+86,258
| +24% | +$289K | ﹤0.01% | 2235 |
|
|
2016
Q4 | $763K | Buy |
353,407
+1,629
| +0.5% | +$3.81K | ﹤0.01% | 2638 |
|
|
2016
Q3 | $1.06M | Buy |
351,778
+158,785
| +82% | +$427K | ﹤0.01% | 2536 |
|
|
2016
Q2 | $492K | Buy |
192,993
+13,743
| +8% | +$38.3K | ﹤0.01% | 2801 |
|
|
2016
Q1 | $528K | Sell |
179,250
-19,996
| -10% | -$107K | ﹤0.01% | 2835 |
|
|
2015
Q4 | $1.63M | Buy |
199,246
+165,367
| +488% | +$1.34M | ﹤0.01% | 2229 |
|
|
2015
Q3 | $242K | Sell |
33,879
-174,443
| -84% | -$1.46M | ﹤0.01% | 2851 |
|
|
2015
Q2 | $1.91M | Buy |
+208,322
| New | +$2M | ﹤0.01% | 2089 |
|
|
2014
Q1 | – | Sell |
-13,617
| Closed | -$132K | – | 3047 |
|
|
2013
Q4 | $132K | Buy |
+13,617
| New | +$128K | ﹤0.01% | 2684 |
|
Other funds holding CDMO
AC
GCL
PAIM
AAM
Renaissance Technologies's CDMO Position: Q4 2024 in Review
Renaissance Technologies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 48,124 shares — an estimated $548K sold.
Renaissance Technologies first reported a position in CDMO in Q4 2013 and held it in 29 quarters. The position peaked at $2.96M in Q2 2021. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.
- Renaissance Technologies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Renaissance Technologies sold 48,124 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $548K.
- Renaissance Technologies first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2013 and held it in 29 quarters.
- Renaissance Technologies's Avid Bioservices, Inc. Common Stock position peaked at $2.96M in Q2 2021.
- 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.